Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Murine T-cell heterogeneity.

A Ahmed, A H Smith, T Folks

    Cancer Treatment Reports
    |April 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Suppressor T cells can promote cancer growth by inactivating anti-tumor immune cells. Understanding T cell heterogeneity is key for developing new cancer immunotherapies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Genomic structure and ecdysone regulation of the prophenoloxidase 1 gene in the malaria vector Anopheles gambiae.

    Proceedings of the National Academy of Sciences of the United States of America·1999
    Same author

    Q wave and non-Q wave myocardial infarction: a multivariate analysis of survival experience and clinical outcome after first diagnosis at a tertiary care hospital.

    JPMA. The Journal of the Pakistan Medical Association·1999
    Same author

    A study of 20 SLE patients with intravenous immunoglobulin--clinical and serologic response.

    Lupus·1999
    Same author

    Complications of traditional male circumcision.

    Annals of tropical paediatrics·1999
    Same author

    Novel endoscopic approach for removal of a rectal foreign body.

    Gastrointestinal endoscopy·1999
    Same author

    Estimating the true extent of cognitive decline in the old old.

    Journal of the American Geriatrics Society·1999
    Same journal

    Rhabdomyolysis associated with high-dose cytarabine.

    Cancer treatment reports·1987
    Same journal

    Acute laryngeal edema after single-dose irradiation and doxorubicin.

    Cancer treatment reports·1987
    Same journal

    Timing may be a critical factor in drug therapy.

    Cancer treatment reports·1987
    Same journal

    Prednimustine in advanced malignant melanoma: a phase II study.

    Cancer treatment reports·1987
    Same journal

    Phase II evaluation of diaziquone in pancreatic carcinoma: a Southwest Oncology Group Study.

    Cancer treatment reports·1987
    Same journal

    Teniposide in metastatic renal and bladder cancer: a Southwest Oncology Group Study.

    Cancer treatment reports·1987
    See all related articles

    Area of Science:

    • Immunology
    • Cancer Research
    • Cell Biology

    Background:

    • Immunoregulatory T cells (T cells) play a role in cancer development by suppressing anti-tumor immune responses.
    • The concept of a balance between effector and suppressor T cells suggests potential for cancer immunotherapy.
    • Animal models, particularly mice, have been instrumental in studying these T cell functions.

    Purpose of the Study:

    • To review current knowledge on functional heterogeneity in murine T cells.
    • To highlight the role of differential cell-surface marker expression in T cell function.
    • To provide insights into T cell-mediated regulation of malignant neoplasms.

    Main Methods:

    • Phenotypic characterization of lymphoid cells using cell-surface markers.

    Related Experiment Videos

  • Investigation of functionally distinct immunologic events mediated by T cell subpopulations.
  • Review of existing studies primarily from murine models.

    • Main Results:

    • Distinct subpopulations of lymphoid cells exist, identifiable by cell-surface markers.
    • Differential expression of markers correlates with specific T cell functions.
    • Suppressor T cells are implicated in facilitating unchecked tumor growth.

    Conclusions:

    • Understanding T cell heterogeneity is crucial for cancer immunotherapy.
    • Targeting suppressor T cells or enhancing effector T cells may offer therapeutic strategies.
    • Further research into T cell surface markers can elucidate their roles in cancer.